News EU approves Pfizer antibiotic for superbug infections Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections.
News GSK reveals data on novel gonorrhoea drug gepotidacin GSK has unveiled the data for its novel antibiotic gepotidacin as a treatment for gonorrhoea, putting the drug on track to become an important therapy for people with resistant forms
Partner Content Partner Content Combating Antifungal Resistance to be discussed at Superbugs... Antifungal Resistance at Superbugs & Superdrugs 2019
Partner Content Partner Content Registration Officially Opens for the 21st Annual Superbugs ... Registration Opens for 21st Superbugs & Superdrugs 2019
News AZ prepares to file blood pressure drug after trial win Two years after buying CinCor for $1.3 billion, AstraZeneca has reported that the main asset in the deal has cleared a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face